Institute for OneWorld Health awarded Skoll Foundation's Social Entrepreneurship Award

San Francisco, Calif. March 21, 2005 The Institute for OneWorld Health today announced that it has been awarded a 2005 Skoll Award for Social Entrepreneurship in the amount of $615,000 over three years. Based in San Francisco, OneWorld Health is the first nonprofit pharmaceutical company in the U.S. and develops new medicines to cure infectious diseases that disproportionately affect the poorest people in the world.

OneWorld Health is one of 13 organizations receiving $7.3 million from the Skoll Foundation through an open competitive process that identifies social entrepreneurs who have piloted innovative programs and are ready to take the next steps toward systemic social change. The awards will be presented on March 31 at the second annual Skoll World Forum on Social Entrepreneurship at Oxford University in England, where some of the world's leading practitioners and thought leaders in social entrepreneurship will convene to set the future agenda for visionaries who want to transform society.

"OneWorld Health is honored to be among this year's Skoll Award recipients," said Dr. Victoria Hale, founder and CEO of the Institute for OneWorld Health. "The Skoll Foundation recognizes the challenges each of our organizations face, and is leading the philanthropic community in its commitment to social innovators."

The Skoll Foundation's mission is to advance systemic change benefiting communities around the world by investing in, connecting and celebrating social entrepreneurs, who are individuals dedicated to creating new solutions that result in lasting improvements to complex social problems.

"We have cast our net far and wide to find the world's best social entrepreneurs," said Sally Osberg, President and CEO of the Skoll Foundation. "OneWorld Health is tackling a complex social problem in order to promote healthy, sustainable communities."


Contact: Joanne Hasegawa
Institute for OneWorld Health

Page: 1

Related biology news :

1. Weizmann Institute scientists discover a control mechanism for metastasis
2. UCLAs California NanoSystems Institute partners with Abraxis BioScience
3. Wiley extends publishing partnership with the American Institute of Chemical Engineers
4. Biodesign Institute leads innovative project to prevent cancer
5. DOE Joint Genome Institute secures long-term lease on production genomics facility
6. Weizmann Institute scientists develop a general control switch for protein activity
7. Research without borders: Head of Santa Fe Institute to address NSF
8. Stowers Institutes Workman Lab demonstrates mechanism for decoding histone modification marks
9. The Institute of Ecosystem Studies recognized by the Wildlife Society
10. 2007 Wistar Institute Science Journalism Award winner announced
11. UCLA AIDS Institute researchers find a peptide that encourages HIV infection

Post Your Comments:

(Date:10/27/2019)... ... October 26, 2019 , ... Since 2010, The HOTH has served over ... the success of their clients, they’ve earned a place on the highly-competitive and desirable ... won many additional awards and accolades along the way. , Now, The HOTH ...
(Date:10/26/2019)... ... October 24, 2019 , ... World Cord Blood Day (WCBD) takes place ... midwives to learn about the current and future uses of cord blood stem cells, ... being used to treat and cure over 80 different life-threatening diseases, including leukemia, lymphoma, ...
(Date:10/26/2019)... ... October 25, 2019 , ... ... therapy in La Plata, MD. Orofacial myofunctional disorders (OMDs) are abnormal movement patterns ... and speaks. This can include anything from difficulty swallowing and limited tongue movement ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the global ... today announces that the U.S. Food and Drug Administration (FDA) has granted the ... temporary relief of chronic neck and shoulder pain of musculoskeletal origin. , Erchonia ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... and reset itself, announced the midway point of its randomized research trial for ... study is to measure the efficacy of a non-invasive technology which compares tones ...
(Date:10/3/2019)... ... 02, 2019 , ... Today marked the official launch of ... program outsourcing success by cultivating radical improvements in leadership, staff, and broader project ... Reese, phaseUP™ brings clients deep, broad and unique expertise in the intricacies of ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D imaging and wound ... by the East Midlands Academic Health Science Network (EMAHSN), the innovation arm of the ... by providing support to develop and deploy solutions to the most pressing challenges facing ...
Breaking Biology Technology:
Cached News: